If your COPD is different, you may need a different kind of treatment. Talk with your doctor about genetic COPD today.

It’s crucial to know if you have genetic COPD, also known as alpha1-antitrypsin deficiency, or alpha-1.

People with alpha-1 may suffer from serious respiratory problems like emphysema and COPD.

Without enough of the protective alpha₁ antitrypsin protein, lungs may be more vulnerable to damage from infections, inflammation, and irritants like dust and smoke.

Talk to your doctor — alpha-1 is treatable

Alpha-1 is a genetic condition, passed down from your parents. Confirming a diagnosis and considering treatment is essential, and only a doctor can diagnose alpha-1. FDA-approved treatment options may be available.

Ready to take the next step?

Find a doctor

Enter your ZIP code, preferred search distance from you and specialty

Begin your search using the fields above

The search results will provide contact information for healthcare professionals near you who have experience testing for alpha-1. The only way you will know for sure if you have alpha-1 is to get tested. If your healthcare professional diagnoses you with alpha-1, treatment options may be available. Talk with your doctor about treatment options.

text

Start the alpha-1 conversation with your healthcare provider.

Questions to ask during your next visit:

  • Could my respiratory symptoms be related to alpha-1, and should we consider testing for it?
  • What are the potential treatment options for someone diagnosed with alpha-1?
  • Are there specialists or resources you recommend for learning more about alpha-1?
  • Did you know there are free, doctors-only test kits to confirm an alpha-1 diagnosis at AlphaID.com?

The COPD Foundation and other leading health organizations recommend that all COPD patients get tested for alpha-1.1-3

Are you at risk for genetic COPD?

It’s free and easy to find out.*

Learn More

*The AlphaID™ At Home Genetic Health Risk Service, including the kit, is provided for free and may not be billed to patients or their insurers. There is no obligation to purchase or use any product or service offered by any manufacturer.

 

References

  1. World Health Organization. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Org. 1997;75(5):397-415.
  2. Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J. The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682.
  3. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. GOLD COPD 2021 report.